Search Results

1 - 10 of 89 items :

  • progression x
  • Life Sciences, other x
Clear All
Comparison of Sojourn Time Distributions in Modeling HIV/AIDS Disease Progression

-246. D’Amico G., Janssen J., Giuseppe D., Monica R. (2009): HIV progression through two different temporal scales according to non-homogeneous semi Markov models. In: Proceedings of the 13th International Conference on Applied Stochastic Models and Data Analysis, Sakalauskas L, Skiadas C (eds.), pp. 473-476. Dessie Z.G. (2014): Modeling of HIV/AIDS dynamic evolution using non- homogeneous semi-Markov process. 3: 2-11. Dessie Z.G. (2014): Multi-State Models of HIV/AIDS by Homogeneous Semi-Markov Process. American Journal of Biostatistics

Open access
Bone sialoprotein as a biochemical marker of subchondral bone turnover

., Nowacki W. 2006. IGF-1, Cytokines and Bone Turnover in Osteoarthritis. Biochemia Medica 16, 127-136. Lohmander L. S., Felson D. 2004. Can we identify a ‘high risk’ patient profile to determine who will experience rapid progression of osteoarthritis? Osteoarthritis Cartilage. 12 Suppl A, 49-52. Lohmander L.S. Saxne T., Heinegård D. 1996. Increased concentrations of bone sialoprotein in joint fluid after knee injury. Ann. Rheum. Dis. 55, 622-666. Mansson B., Geborek P., Saxne T. 1997

Open access
Omega-3 polyunsaturated fatty acids of fish and their role in cancerous cell lines: A review of in-vitro studies

. 62: 821-828. Arterburn L.M., Hall E.B., Oken H. 2006 - Distribution, interconversion, and dose response of n-3 fatty acids in humans - Am. J. Clin. Nutr. 83: 1467S-1476S. Baracos V.E., Mazurak V.C., Ma D.W.L.2004 - n-3 Polyunsaturated fatty acids throughout the cancer trajectory: influence on disease incidence, progression, response to therapy and cancer-associated cachexia - Nutr. Res. Rev. 17: 177-192. Barascu A., Besson P., Le Floch O., Bougnoux P., Jourdan M.L. 2006 - CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3

Open access
Physiopathological Implications of 7TM Receptors

-Yehudah, A., Lorberboum-Galski, H. 2004. Surface antigens/receptors for targeted cancer treatment: the GnRH receptor/binding site for targeted adenocarcinoma therapy. Curr. Cancer Drug Targets. 4: 673-687. Filardo, E. J., Graeber, C. T., Quinn, J. A., Resnick, M. B., Giri, D., DeLellis, R. A., Steinhoff, M. M., Sabo, E. 2006. Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin. Cancer Res. 12: 6359

Open access
Overgrowing of two polymictic lakes in Central-Western Poland

, Hydrobiologia 488: 27-41. Van der Putten W. H., 1997, Die-Back of Phragmites australis in European wetlands: an overview of the European Research Programme on Reed Die-back and Progression (1993-1994), Aquat. Bot. 59: 263-275.

Open access
Vascular Endothelial Growth Factor (VEGF) in Abdominal Fluid in Dogs with Oncological and Non-Oncological Diseases

-0142(19990101)85:1<178::AID-CNCR25>3.0.CO;2-7 21. Rudlowski, C., Pickart, A.K., Fuhljahn, C., Friepoertner, T., Schlehe, B., Biesterfeld, S., Schroeder, W. (2006). Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up. Int J Gynecol Cancer. 16(1): 183-189. https://doi.org/10.1136/ijgc-00009577-200602001-00029 PMid:16515588 22. Roskoski, J.R. (2007). Vascular endothelial growth factor (VEGF) signaling in tumor progression. Critical Reviews in Oncology/Hematology 62, 179-213. https://doi.org/10.1016/j

Open access
Contribution of non-pollen palynomorphs to reconstructions of land-use changes and lake eutrophication: case study from Lake Jaczno, northeastern Poland

dynamics, Kretzschmaria deusta attack, and mire hydrology as palaeoecological proxies for mid-Holocene climate reconstruction in the Kashubian Lake District (N Poland), Holocene 23(5): 667–677. Leeben A., Freiberg R., Tonno I., Koiv T., Alliksaar T., Heinsalu A., 2013, A comparison of the palaeolimnology of Peipsi and Võrtsjärv: connected shallow lakes in north-eastern Europe for the twentieth century, especially in relation to eutrophication progression and water-level fluctuations, Hydrobiologia 710(1): 227–240. López-Merino L., Sánchez N.S., Kaal J., López

Open access
Expression of small GTPases in the roots and nodules of Medicago truncatula cv. Jemalong

proteins. Molecular and Cellular Proteomics 14, 1301–1322. Craddock, C., Lavagi, I., Yang, Z. 2012: New insights into Rho signaling from plant ROP/Rac GTPases. Trends in Cell Biology 22, 492–501. Dalla Via, V., Traubenik, S., Rivero, C., Aguilar, O. M., Zanetti, M. E., Blanco, F. A. 2017: The monomeric GTPase RabA2 is required for progression and maintenance of membrane integrity of infection threads during root nodule symbiosis. Plant Molecular Biology 93, 549–562. Damiani, I., Drain, A., Guichard, M., Balzergue, S., Boscari, A., Boyer, J.-C., Brunaud

Open access
Screening of early diagnostic markers of gentamicin-induced acute kidney injury in canines

kidney injury and predicts progression to ESRD in type I diabetes. J Am Soc Nephrol 2014, 25, 2177–2186. Sabbisetti V.S. Waikar S.S. Antoine D.J. Smiles A. Wang C. Ravisankar A. Ito K. Sharma S. Ramadesikan S. Lee M. Briskin R. De Jager P.L. Ngo T.T. Radlinski M. Dear J.W. Park K.B. Betensky R. Krolewski A.S. Bonventre J.V. Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes J Am Soc Nephrol 2014 25 2177

Open access
Endocannabinoid system and anticancer properties of cannabinoids

Neurochemistry, 72(5): 2113–2119. Bowles, D.W., O’Bryant, C.L., Camidge, D.R., & Jimeno, A., 2012. The intersection between cannabis and cancer in the United States. Critical Reviews in Oncology/Hematology, 83(1): 1–10. Cabral, G. A., Raborn, E. S., Griffin, L., Dennis, J., Marciano-Cabral, F., 2008. CB2 receptors in the brain: role in central immune function. British Journal of Pharmacology, 153(2): 240–251. Caffarel, M.M., Sarrió, D., Palacios, J., Guzmán, M., & Sánchez, C., 2006. Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast

Open access